Answers are grounded in this paper and cite their sources.
The understanding of the diversity within FRDA populations and their patterns of functional decline provides an essential foundation for future clinical trial design including patient selection and facilitates the interpretation of the clinical relevance of progression detected in FRDA.
No takes yet. Share an insight, caveat, or question.
Rummey et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: